Early Phase Human Drug Trial to Investigate DYN101 in Participants 2 to 17 Years With Centronuclear Myopathies
Condition: Centronuclear Myopathy Intervention: Drug: DYN101 Sponsor: Dynacure Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Centronuclear Myopathies | Research